All ten studies used either abdominal ultrasound alone (n = 8) or abdominal ultrasound along with elevated liver enzymes [alanine aminotransferase (ALT) > 40 U/L] (n = 2) to identify NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.